Catalyst Pharmaceuticals Inc Working Capital to Net Assets Ratio
Catalyst Pharmaceuticals Inc working capital to net assets ratio. Catalyst Pharmaceuticals Inc (CPRX) has a Working Capital to Net Assets ratio of 79.8% as of March 2026. Working capital of $807.99 Million (current assets of $940.39 Million minus current liabilities of $132.40 Million) is measured against net assets of $1.01 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Catalyst Pharmaceuticals Inc (CPRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Catalyst Pharmaceuticals Inc (2004–2025)
Working capital to net assets ratio of Catalyst Pharmaceuticals Inc from 2004 to 2025. This chart shows how Catalyst Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 79.8%, reflecting working capital of $807.99 Million against net assets of $1.01 Billion USD. See CPRX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Catalyst Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2004–2025)
Catalyst Pharmaceuticals Inc working capital to net assets ratio by year from 2004 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Catalyst Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Catalyst Pharmaceuticals Inc assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 78.3% | $746.88 Million | $954.27 Million | $894.03 Million | $147.15 Million | ▲ +9.1 pp |
| 2024 | 69.1% | $502.93 Million | $727.63 Million | $623.61 Million | $120.68 Million | ▲ +32.2 pp |
| 2023 | 36.9% | $143.27 Million | $387.88 Million | $219.33 Million | $76.06 Million | ▼ -50.7 pp |
| 2022 | 87.6% | $263.22 Million | $300.42 Million | $320.81 Million | $57.59 Million | ▼ -0.9 pp |
| 2021 | 88.5% | $183.04 Million | $206.83 Million | $210.11 Million | $27.06 Million | ▲ +8.0 pp |
| 2020 | 80.5% | $136.49 Million | $169.60 Million | $159.24 Million | $22.76 Million | ▼ -19.1 pp |
| 2019 | 99.6% | $87.26 Million | $87.63 Million | $111.36 Million | $24.10 Million | ▲ +9.6 pp |
| 2018 | 89.9% | $45.68 Million | $50.78 Million | $55.19 Million | $9.51 Million | ▼ -10.0 pp |
| 2017 | 99.9% | $80.92 Million | $80.96 Million | $85.19 Million | $4.27 Million | ▼ -0.2 pp |
| 2016 | 100.1% | $39.36 Million | $39.31 Million | $41.45 Million | $2.09 Million | ▼ -1.6 pp |
| 2015 | 101.8% | $56.46 Million | $55.48 Million | $59.90 Million | $3.44 Million | ▼ -6.0 pp |
| 2014 | 107.7% | $37.97 Million | $35.24 Million | $43.83 Million | $5.86 Million | ▼ -0.6 pp |
| 2013 | 108.4% | $23.18 Million | $21.39 Million | $25.32 Million | $2.14 Million | ▲ +5.2 pp |
| 2012 | 103.1% | $15.08 Million | $14.62 Million | $16.73 Million | $1.65 Million | ▼ -40.3 pp |
| 2011 | 143.4% | $5.39 Million | $3.76 Million | $6.23 Million | $833.80K | ▲ +44.2 pp |
| 2010 | 99.3% | $5.48 Million | $5.52 Million | $5.78 Million | $298.96K | ▼ -0.4 pp |
| 2009 | 99.7% | $7.59 Million | $7.62 Million | $7.89 Million | $294.15K | ▲ +0.4 pp |
| 2008 | 99.3% | $10.49 Million | $10.56 Million | $11.92 Million | $1.43 Million | ▼ -0.1 pp |
| 2007 | 99.4% | $16.23 Million | $16.32 Million | $16.53 Million | $303.29K | ▼ -0.4 pp |
| 2006 | 99.8% | $19.81 Million | $19.85 Million | $20.59 Million | $772.85K | ▲ +3.8 pp |
| 2005 | 96.0% | $428.58K | $446.46K | $771.57K | $342.99K | ▼ -2.8 pp |
| 2004 | 98.8% | $116.11K | $117.58K | $183.91K | $67.80K | — |